Piper Sandler analyst Casey Orr Whitman reinstates Citizens & Northern (NASDAQ:CZNC) with a Neutral and announces $26 price target.
Harrow To Launch FDA-Approved IHEEZO At The 2023 American Society Of Cataract And Refractive Surgery Annual Meeting
Harrow (NASDAQ:HROW), a leading U.S. eyecare pharmaceutical company, today announced the launch of FDA-approved IHEEZO™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting
